Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
Reading Time: < 1 minute
Topic: Antiviral Therapeutics
Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection
Reading Time: < 1 minute
Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
Reading Time: < 1 minute
Immunogenicity of a recombinant plant-produced respiratory syncytial virus F subunit vaccine in mice
Reading Time: < 1 minute
Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis
Reading Time: < 1 minute
Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
Reading Time: < 1 minute
Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
Reading Time: < 1 minute
Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
Reading Time: < 1 minute
Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
Reading Time: < 1 minute
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
Reading Time: < 1 minute